U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C3H3N3O2
Molecular Weight 113.0748
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-NITROIMIDAZOLE

SMILES

[O-][N+](=O)C1=CNC=N1

InChI

InChIKey=VYDWQPKRHOGLPA-UHFFFAOYSA-N
InChI=1S/C3H3N3O2/c7-6(8)3-1-4-2-5-3/h1-2H,(H,4,5)

HIDE SMILES / InChI

Molecular Formula C3H3N3O2
Molecular Weight 113.0748
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.
2010-12-21
Study on ITS1 Gene of Iranian Trichomonas vaginalis by Molecular Methods.
2010-12
New 4-thiazolidinones of nicotinic acid with 2-Amino-6-methylbenzothiazole and their biological activity.
2010-09-26
Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
2010-09
Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
2010-08
Simultaneous Determination of Ofloxacin and Ornidazole in Solid Dosage Form by RP-HPLC and HPTLC Techniques.
2010-07
A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.
2010-07
2-Chloro-4-nitro-1H-imidazole.
2010-06-26
Cationic nucleoside lipids derived from universal bases: A rational approach for siRNA transfection.
2010-06-16
Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole.
2010-06
Documentation of in vivo and in vitro aerobic resistance of feline Tritrichomonas foetus isolates to ronidazole.
2010-05-25
The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
2010-05
The tropical brown alga Lobophora variegata: a source of antiprotozoal compounds.
2010-04-16
Selectivity of Enzymatic Conversion of Oligonucleotide Probes during Nucleotide Polymorphism Analysis of DNA.
2010-04
Biophysical characterization and mutational analysis of the antibiotic resistance protein NimA from Deinococcus radiodurans.
2010-04
Ronidazole toxicosis in 3 society finches (Lonchura striata).
2010-03
[Tetracyclines, sulfonamides, and metronidazole].
2010-02
Synthesis and cloxacillin antimicrobial enhancement of 2-methylsulfonylimidazolyl-1,4-dihydropyridine derivatives.
2010
Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
2010
In vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: variability and variation in gene expression.
2009-12
Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron.
2009-08
Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.
2009-07-09
Guidelines for the treatment of bacterial vaginosis: focus on tinidazole.
2009-06
[Tinidazole: a classical anaerobical drug with multiple potential uses nowadays].
2009-06
Diffuse alveolar haemorrhage due to 5-nitroimidazole treatment.
2009-05
Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
2009-04
Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles.
2009-03-12
Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
2009-02-12
Validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of 5-nitroimidazole drugs and their corresponding hydroxy metabolites in lyophilised pork meat.
2009-01-09
Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.
2009
In vitro activity of Arbutus unedo leaf extracts against Trichomonas vaginalis trophozoites.
2009
The old and new therapeutic approaches to the treatment of giardiasis: where are we?
2009
On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
2008-10-01
Toxicology.
2008-10
[Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
2008-08-12
Genotoxicity and cell death induced by tinidazole (TNZ).
2008-07-30
NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer.
2008-07-10
Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.
2008-06-07
High-resolution structure of the antibiotic resistance protein NimA from Deinococcus radiodurans.
2008-06-01
A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis.
2008-06
Use of molecularly imprinted solid-phase extraction sorbent for the determination of four 5-nitroimidazoles and three of their metabolites from egg-based samples before tandem LC-ESIMS/MS analysis.
2008-05-28
The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide.
2008-04
Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin.
2007-12
Synthesis, antibacterial activity, and quantitative structure-activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3(2H)-benzofuranone derivatives.
2007-11-15
Sequential regimens for Helicobacter pylori eradication.
2007-09-22
Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
2007-08
Two different modes of halogen bonding in two 4-nitroimidazole derivatives.
2007-08
Crystal packing of two 5-substituted 2-methyl-4-nitro-1H-imidazoles.
2007-08
Nitroimidazoles, part 2: Synthesis, antiviral and antitumor activity of new 4-nitroimidazoles.
2006-05
Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro.
1996-12
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:58:24 GMT 2025
Edited
by admin
on Mon Mar 31 18:58:24 GMT 2025
Record UNII
Y8U32AZ5O7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-50359
Preferred Name English
4-NITROIMIDAZOLE
Systematic Name English
IMIDAZOLE, 4-NITRO-
Systematic Name English
1H-IMIDAZOLE, 5-NITRO-
Systematic Name English
NITROIMIDAZOLE, 4-
Systematic Name English
IMIDAZOLE, 4(OR 5)-NITRO-
Systematic Name English
5-NITROIMIDAZOLE
Systematic Name English
1H-IMIDAZOLE, 4-NITRO-
Systematic Name English
1H-5-NITROIMIDAZOLE
Common Name English
Code System Code Type Description
PUBCHEM
18208
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
FDA UNII
Y8U32AZ5O7
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
NSC
50359
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
MESH
C052587
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
EPA CompTox
DTXSID9062803
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
ECHA (EC/EINECS)
221-224-7
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
CAS
3034-38-6
Created by admin on Mon Mar 31 18:58:24 GMT 2025 , Edited by admin on Mon Mar 31 18:58:24 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY